The Orphan Drug Premium: Analyzing the Financial Incentives and...

adicionou um novo artigo Health

2025-11-18 11:06:49 -

The Orphan Drug Premium: Analyzing the Financial Incentives and Pricing Strategies Driving Innovation in the Duchenne Muscular Dystrophy Market.

The Duchenne Muscular Dystrophy (DMD) market is fundamentally shaped by the economics of rare diseases, operating under the Orphan Drug framework established by legislation like the U.S. Orphan Drug Act. These incentives—extended market exclusivity, tax credits, and accelerated review—are essential to de-risk the massive R&D investment required for a small patient population....

0 Comentários 0 Compartilhamentos 46 Visualizações 0 Anterior